The defucosylated human anti-CCR4 antibodies also demonstrated strong ADCC activity against Hodgkin’s lymphoma and cutaneous T-cell lymphoma cell lines (Figure 10f, g, Table S4c in File S1) and against the autologous Treg cells (Figure 10h). Here, CCR4 is linked to Hodgkins lymphoma.